|
FAM172A expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.939200E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.242900E-03 |
| Normal-vs-Stage2 |
5.984600E-01 |
| Normal-vs-Stage3 |
7.750800E-01 |
| Normal-vs-Stage4 |
6.024100E-04 |
| Stage1-vs-Stage2 |
3.379200E-01 |
| Stage1-vs-Stage3 |
1.589670E-02 |
| Stage1-vs-Stage4 |
1.37879999639878E-08 |
| Stage2-vs-Stage3 |
4.694000E-01 |
| Stage2-vs-Stage4 |
1.281920E-02 |
| Stage3-vs-Stage4 |
5.895600E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.213200E-01 |
| Normal-vs-AfricanAmerican |
1.782390E-01 |
| Normal-vs-Asian |
1.617240E-01 |
| Caucasian-vs-AfricanAmerican |
6.032300E-02 |
| Caucasian-vs-Asian |
2.948400E-01 |
| AfricanAmerican-vs-Asian |
7.155200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.907400E-01 |
| Normal-vs-Female |
4.169000E-01 |
| Male-vs-Female |
7.902600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.402800E-01 |
| Normal-vs-Age(41-60Yrs) |
6.133600E-01 |
| Normal-vs-Age(61-80Yrs) |
2.002000E-01 |
| Normal-vs-Age(81-100Yrs) |
9.388200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.269800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.441150E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.626000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.989600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.921800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.424200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.868400E-01 |
| Normal-vs-Grade 2 |
3.432400E-04 |
| Normal-vs-Grade 3 |
6.063200E-01 |
| Normal-vs-Grade 4 |
2.13369999999546E-05 |
| Grade 1-vs-Grade 2 |
3.396800E-01 |
| Grade 1-vs-Grade 3 |
3.761800E-01 |
| Grade 1-vs-Grade 4 |
3.062900E-03 |
| Grade 2-vs-Grade 3 |
5.54939999999338E-05 |
| Grade 2-vs-Grade 4 |
5.56465984402621E-12 |
| Grade 3-vs-Grade 4 |
1.190460E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
9.69679999962558E-07 |
| Normal-vs-ccB subtype |
8.894400E-02 |
| ccA subtype-vs-ccB subtype |
1.14400000583714E-09 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.141000E-01 |
| Normal-vs-N1 |
2.694100E-02 |
| N0-vs-N1 |
1.149960E-02 |
|
|
